Skin microbiota of oxazolone-induced contact hypersensitivity mouse model.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
05
2022
accepted:
28
09
2022
entrez:
20
10
2022
pubmed:
21
10
2022
medline:
25
10
2022
Statut:
epublish
Résumé
Contact allergy is a common skin allergy, which can be studied utilising contact hypersensitivity (CHS) animal model. However, it is not clear, whether CHS is a suitable model to investigate skin microbiota interactions. We characterised the effect of contact dermatitis on the skin microbiota and studied the biological effects of oxazolone (OXA) -induced inflammation on skin thickness, immune cell numbers and changes of the microbiota in CHS mouse model (n = 72) for 28 days. Through 16S rRNA gene sequencing we defined the composition of bacterial communities and associations of bacteria with inflammation. We observed that the vehicle solution of acetone and olive oil induced bacterial community changes on day 1, and OXA-induced changes were observed mainly on day 7. Many of the notably enriched bacteria present in the OXA-challenged positive group represented the genus Faecalibaculum which were most likely derived from the cage environment. Additionally, skin inflammation correlated negatively with Streptococcus, which is considered a native skin bacterium, and positively with Muribacter muris, which is typical in oral environment. Skin inflammation favoured colonisation of cage-derived faecal bacteria, and additionally mouse grooming transferred oral bacteria on the skin. Due to the observed changes, we conclude that CHS model could be used for certain skin microbiome-related research set-ups. However, since vehicle exposure can alter the skin microbiome as such, future studies should include considerations such as careful control sampling and statistical tests to account for potential confounding factors.
Identifiants
pubmed: 36264944
doi: 10.1371/journal.pone.0276071
pii: PONE-D-22-13700
pmc: PMC9584374
doi:
Substances chimiques
Oxazolone
15646-46-5
RNA, Ribosomal, 16S
0
Olive Oil
0
Acetone
1364PS73AF
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0276071Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Invest Dermatol. 2013 Feb;133(2):303-15
pubmed: 22931926
J Allergy Clin Immunol. 2014 Dec;134(6):1301-1309.e11
pubmed: 25262465
J Eur Acad Dermatol Venereol. 2022 May;36(5):705-716
pubmed: 35015907
Nucleic Acids Res. 1989 Oct 11;17(19):7843-53
pubmed: 2798131
Ecol Lett. 2017 May;20(5):561-576
pubmed: 28317296
Nature. 2018 Jan 24;553(7689):427-436
pubmed: 29364286
Front Nutr. 2021 May 03;8:667744
pubmed: 34012974
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Acta Pathol Microbiol Immunol Scand B. 1986 Feb;94(1):1-8
pubmed: 3728022
Part Fibre Toxicol. 2014 Aug 14;11:38
pubmed: 25123235
APMIS. 2012 Jan;120(1):1-27
pubmed: 22151305
ISME J. 2020 Oct;14(10):2367-2380
pubmed: 32518248
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8334-9
pubmed: 22566627
J Invest Dermatol. 2010 Dec;130(12):2743-51
pubmed: 20631725
J Invest Dermatol. 2019 Apr;139(4):878-889
pubmed: 30423328
Mucosal Immunol. 2019 Nov;12(6):1348-1357
pubmed: 31554900
Front Immunol. 2021 Mar 17;12:650621
pubmed: 33815411
Toxicol Sci. 2015 Sep;147(1):140-55
pubmed: 26048651
Clin Exp Allergy. 2017 Jun;47(6):805-814
pubmed: 28198584
Sci Rep. 2020 Dec 3;10(1):21204
pubmed: 33273678
Yale J Biol Med. 2020 Dec 29;93(5):699-709
pubmed: 33380932
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Genome Biol. 2014;15(12):550
pubmed: 25516281
Semin Immunol. 2013 Nov 30;25(5):370-7
pubmed: 24268438
Curr Protoc Immunol. 2016 Apr 01;113:4.2.1-4.2.7
pubmed: 27038464
Br J Dermatol. 2013 Jan;168(1):39-46
pubmed: 22834538
Science. 2019 Aug 2;365(6452):
pubmed: 31371577
Microbiome. 2018 Dec 17;6(1):226
pubmed: 30558668
Trends Ecol Evol. 2015 Dec;30(12):766-779
pubmed: 26519235
Diabetes. 2013 Mar;62(3):923-30
pubmed: 23139351
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Methods Ecol Evol. 2020 Mar;11(3):442-447
pubmed: 32194928
Nat Methods. 2013 Dec;10(12):1200-2
pubmed: 24076764
J Invest Dermatol. 2012 Dec;132(12):2744-51
pubmed: 22739792
J Immunol. 2000 Dec 15;165(12):6783-90
pubmed: 11120799
Science. 2012 Apr 27;336(6080):489-93
pubmed: 22442383
J Invest Dermatol. 2016 May;136(5):947-956
pubmed: 26829039
J Invest Dermatol. 2020 Aug;140(8):1619-1628.e2
pubmed: 31981578
J Dig Dis. 2013 Oct;14(10):526-35
pubmed: 23734583
Contact Dermatitis. 2019 Feb;80(2):77-85
pubmed: 30370565
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Antonie Van Leeuwenhoek. 2015 Dec;108(6):1309-1318
pubmed: 26349481
Int Arch Allergy Immunol. 2017;173(1):23-33
pubmed: 28482341
Sci Rep. 2017 Mar 14;7:44385
pubmed: 28290517
Mol Biol Rep. 2019 Jun;46(3):3225-3232
pubmed: 30937654
Microbiome. 2019 Feb 19;7(1):28
pubmed: 30782206
Int J Syst Evol Microbiol. 2015 Oct;65(10):3344-3351
pubmed: 26296776
Ann Allergy Asthma Immunol. 2021 Jan;126(1):32-39
pubmed: 33091591